(NASDAQ: LNTH) Lantheus Holdings's forecast annual revenue growth rate of 6.77% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 9.29%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.69%.
Lantheus Holdings's revenue in 2026 is $1,546,178,000.On average, 16 Wall Street analysts forecast LNTH's revenue for 2026 to be $97,073,168,262, with the lowest LNTH revenue forecast at $90,953,196,554, and the highest LNTH revenue forecast at $108,206,308,284. On average, 15 Wall Street analysts forecast LNTH's revenue for 2027 to be $109,313,111,678, with the lowest LNTH revenue forecast at $100,328,472,362, and the highest LNTH revenue forecast at $127,021,965,982.
In 2028, LNTH is forecast to generate $122,790,070,652 in revenue, with the lowest revenue forecast at $108,466,732,612 and the highest revenue forecast at $143,298,486,482.